ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) Surges Nearly 6% Intraday, NAV Approximately HKD 3.789
NewTimeSpace News: As of 15:25 on June 8, ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) rose 5.77% to HKD 3.740, with turnover of HKD 9.5632 million and turnover ratio of 5.16%.
NewTimeSpace News: As of 15:25 PM on June 8, ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) rose 5.77% to HKD 3.740, with turnover of HKD 9.5632 million and total AUM of approximately HKD 186 million. According to the latest data from the Hong Kong Stock Exchange, the ETF recorded a high of HKD 3.800, a low of HKD 3.732, an average price of HKD 3.768, a latest NAV of HKD 3.789, a premium/discount rate of -6.67%, and a turnover ratio of 5.16%.
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) comprises 100 of the largest non-financial companies listed on the Nasdaq stock market, weighted by market capitalization. Its constituents include global technology giants such as Apple, Microsoft, NVIDIA, Amazon, Meta, and Tesla, collectively reflecting the overall performance of leading companies in the technology, consumer, and communication sectors.
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) comprises 100 of the largest non-financial companies listed on the Nasdaq stock market, weighted by market capitalization. Its constituents include global technology giants such as Apple, Microsoft, NVIDIA, Amazon, Meta, and Tesla, collectively reflecting the overall performance of leading companies in the technology, consumer, and communication sectors.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags:
- Apollo Future Mobility (00860.HK): Delivers First Apollo EVO Production Custom Edition; Base Price Approximately EUR 3 Million
- CCTC(06951.HK) will spend CNY 261.44 million to repurchase 2.47 million shares on Jul 23, 2026
- CHERISH SUN (01094.HK) plans to issue up to 118.5 million shares by placement, with estimated net proceeds of HKD 24 million
- Grand Pharmaceutical (00512.HK): TCM Class 1.1 Innovative Drug GPN01360 Completes First Patient Enrollment in Phase III Depression Study
- Nanhua Futures (02691.HK): Singapore Subsidiary Obtains Updated CMS Licence, Adding Securities Trading and Custody Services